FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases

Table 1 Patient characteristics

	Number of patients = 9
Male/Female	3/6
Median Age (Range)	63 (46-77) years
Disease stage	at diagnosis	at start of FCR
I	1	0
II	1	5
III	1	3
IV	6	1
Bone marrow involvement
0%	7
10% to ≤ 25%	2
Extranodal involvement	1 (liver)
FLIPI
Low	1
Low-intermediate	6
Intermediate-high	2
Bulky disease	1
B-symptoms	0
Prior therapy including rituximab
No	2
Yes	7
Number of previous regimens
1	2
2	5
>2	2

ISSN: 1756-9966